Drug intelligence / Profile preview

Allogeneic mesenchymal stromal cells (VA Office of Research and Development)

Development stage
Unknown
Lead developer
VA Office of Research & Development
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Allogeneic mesenchymal stromal cells (MSCs) are an investigational cell therapy being developed by the VA Office of Research and Development for the treatment of abdominal aortic aneurysms (AAA). The therapy involves the intravenous infusion of donor-derived MSCs, which are hypothesized to modulate the immune response by inducing regulatory T cells (Tregs) and reducing chronic inflammation within the aortic wall. By shifting the inflammatory environment, the treatment aims to slow the progression and enlargement of small aneurysms, potentially reducing the risk of rupture and the need for surgical intervention. This approach is currently being evaluated in the Phase 1 VIVAAA/ARREST clinical trial.

Other names
Allogeneic mesenchymal stromal cellsAllogeneic MSCsMesenchymal stem cells

Beyond the preview

Go deeper on Allogeneic mesenchymal stromal cells (VA Office of Research and Development).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allogeneic mesenchymal stromal cells (VA Office of Research and Development).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call